Company intelligence / Profile preview

Halodoc

Jakarta, Jakarta Special Capital Region, Indonesiahalodoc.com ↗

Ownership: Private
Employees: ~500
Development stage: Commercial

Overview

Halodoc has demonstrated significant impact in Indonesia by providing over 20 million users monthly with access to teleconsultations with more than 20,000 licensed doctors and facilitating medicine delivery from a network of nearly 5,000 pharmacies. The company played a key role in national COVID‑19 testing and vaccination campaigns. Its integrated platform also offers lab tests at home and insurance connectivity[1][2][5][8].

Therapeutic areas: OtherInfectious Diseases
Modalities: Non-pharmacological therapy (telemedicine)Device (mobile app/healthcare platform)
Industry: Non-Academic Healthcare

Partnerships

Indonesian Ministry of Health for COVID‑19 vaccinations/testingAstra International Tbk (lead investor)

Beyond the preview

Go deeper on Halodoc.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Halodoc.

Explore the full profile